UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002599
Receipt number R000003173
Scientific Title Clinical impact of ghrelin on chronic respiratory infection
Date of disclosure of the study information 2009/11/01
Last modified on 2012/05/02 16:14:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical impact of ghrelin on chronic respiratory infection

Acronym

Ghrelin administration to patients with chronic respiratory infection

Scientific Title

Clinical impact of ghrelin on chronic respiratory infection

Scientific Title:Acronym

Ghrelin administration to patients with chronic respiratory infection

Region

Japan


Condition

Condition

chronic respiratory infection

Classification by specialty

Medicine in general Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

suppression of airway inflammation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

neutrophil in sputum

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Human ghrelin (2 microgram/kg, 20 mL solution) was intravenously administered to the patients for 30 min at a constant rate before breakfast and dinner for 3 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

patients with low BMI (<21), continuous emptysis of sputum, detection of significant pathogen in the sputum

Key exclusion criteria

Patients with diabetes mellitus, severe cardiac disease, liver dysfunction, renal dysfunction, or any infection

Target sample size

7


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masamitsu Nakazato

Organization

University of Miyazaki

Division name

Third Department of Internal Medicine

Zip code


Address

Kihara 5200, Kiyotake, Miyazaki

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

University of Miyazaki

Division name

Third Department of Internal Medicine

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

University of Miyazaki

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 10 Month 31 Day

Date of IRB


Anticipated trial start date

2009 Year 01 Month 01 Day

Last follow-up date

2011 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 10 Month 08 Day

Last modified on

2012 Year 05 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003173


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name